Jubilee Brown

5.5k total citations · 1 hit paper
130 papers, 3.3k citations indexed

About

Jubilee Brown is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Jubilee Brown has authored 130 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Reproductive Medicine, 48 papers in Obstetrics and Gynecology and 33 papers in Oncology. Recurrent topics in Jubilee Brown's work include Ovarian cancer diagnosis and treatment (59 papers), Endometrial and Cervical Cancer Treatments (44 papers) and Cancer Genomics and Diagnostics (12 papers). Jubilee Brown is often cited by papers focused on Ovarian cancer diagnosis and treatment (59 papers), Endometrial and Cervical Cancer Treatments (44 papers) and Cancer Genomics and Diagnostics (12 papers). Jubilee Brown collaborates with scholars based in United States, United Kingdom and Spain. Jubilee Brown's co-authors include Michael Frumovitz, David M. Gershenson, R. Wendel Naumann, Michael T. Deavers, Lois M. Ramondetta, Pedro T. Ramírez, Charlotte C. Sun, Anil K. Sood, Mark F. Munsell and Ricardo dos Reis and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Jubilee Brown

123 papers receiving 3.2k citations

Hit Papers

Clinical Activity and Safety of the Anti–Programmed Death... 2020 2026 2022 2024 2020 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical Activity and Safety of the Anti–Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair–Deficient Endometrial Cancer
    2020 237 citations Ana Oaknin, Anna V. Tinker et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jubilee Brown United States 32 1.6k 1.2k 877 825 487 130 3.3k
Cor D. de Kroon Netherlands 34 1.3k 0.8× 1.7k 1.4× 768 0.9× 632 0.8× 300 0.6× 118 3.4k
Linda Duska United States 35 2.1k 1.3× 1.9k 1.6× 1.2k 1.4× 845 1.0× 403 0.8× 232 4.4k
Lee-may Chen United States 30 1.5k 0.9× 924 0.8× 1.3k 1.4× 543 0.7× 372 0.8× 110 3.4k
Susan C. Modesitt United States 36 1.3k 0.8× 1.1k 0.9× 1.0k 1.1× 760 0.9× 315 0.6× 130 3.7k
Ritu Salani United States 36 2.3k 1.4× 1.8k 1.5× 1.3k 1.5× 1.3k 1.6× 288 0.6× 165 4.6k
Shohreh Shahabi United States 26 860 0.5× 1.2k 1.0× 534 0.6× 453 0.5× 304 0.6× 123 2.8k
Joseph L. Kelley United States 33 1.1k 0.7× 1.7k 1.4× 518 0.6× 987 1.2× 266 0.5× 129 3.0k
Jose Alejandro Rauh‐Hain United States 24 1.0k 0.6× 1.4k 1.1× 498 0.6× 685 0.8× 190 0.4× 120 3.8k
David E. Parkin United Kingdom 29 2.5k 1.6× 1.9k 1.6× 1.1k 1.2× 1.1k 1.3× 275 0.6× 93 4.3k
Christine H. Holschneider United States 25 1.5k 0.9× 1.4k 1.1× 605 0.7× 1.0k 1.3× 166 0.3× 67 3.0k

Countries citing papers authored by Jubilee Brown

Since Specialization
Citations

This map shows the geographic impact of Jubilee Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jubilee Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jubilee Brown more than expected).

Fields of papers citing papers by Jubilee Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jubilee Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jubilee Brown. The network helps show where Jubilee Brown may publish in the future.

Co-authorship network of co-authors of Jubilee Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Jubilee Brown. A scholar is included among the top collaborators of Jubilee Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jubilee Brown. Jubilee Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Brown, Jubilee, Ziqing Yu, Meghan K. Wally, et al.. (2023). Opioid and benzodiazepine use in gynecologic oncology patients. International Journal of Gynecological Cancer. 33(5). 786–791. 4 indexed citations
3.
Oaknin, Ana, Lucy Gilbert, Anna V. Tinker, et al.. (2023). A plain language summary of results from the GARNET study of dostarlimab in patients with endometrial cancer. Future Oncology. 19(25). 1709–1714. 1 indexed citations
4.
Tinker, Anna V., Renaud Sabatier, Adriano Gravina, et al.. (2022). 2022-RA-1198-ESGO Post hoc analysis of objective response rate by mismatch repair protein dimer loss/mutation status in patients with mismatch repair deficient endometrial cancer treated with dostarlimab. International Journal of Gynecological Cancer. 32. A414–A414. 5 indexed citations
5.
Hughes, Brittany N., Thomas J. Herzog, Jubilee Brown, & R. Wendel Naumann. (2021). Opportunistic Salpingectomy at Time of Nongynecologic Elective Procedures Could Reduce Ovarian Cancer–Related Costs and Mortality. Journal of Gynecologic Surgery. 38(1). 43–48. 7 indexed citations
6.
Fader, Amanda N., Warner K. Huh, Joshua P. Kesterson, et al.. (2021). When to Operate, Hesitate and Reintegrate: Society of Gynecologic Oncology Surgical Considerations During the COVID-19 Pandemic. Obstetrical & Gynecological Survey. 76(2). 88–90. 3 indexed citations
7.
Naumann, R. Wendel, et al.. (2021). The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage. American Journal of Obstetrics and Gynecology. 225(4). 397.e1–397.e6. 19 indexed citations
8.
Brown, Jubilee, et al.. (2020). Pre-emptive Non-narcotic Pain Medication before Minimally Invasive Surgery in Gynecologic Oncology. Journal of Minimally Invasive Gynecology. 28(4). 811–816. 4 indexed citations
9.
El‐Deiry, Wafik S., Richard M. Goldberg, Heinz‐Josef Lenz, et al.. (2019). The current state of molecular testing in the treatment of patients with solid tumors, 2019. CA A Cancer Journal for Clinicians. 69(4). 305–343. 187 indexed citations
10.
Brown, Jubilee, et al.. (2019). Workplace Harassment and Discrimination in Gynecology: Results of the AAGL Member Survey. Journal of Minimally Invasive Gynecology. 26(5). 838–846. 33 indexed citations
11.
Naumann, R. Wendel, Robert L. Coleman, Jubilee Brown, & Kathleen N. Moore. (2019). Phase III trials in ovarian cancer: The evolving landscape of front line therapy. Gynecologic Oncology. 153(2). 436–444. 14 indexed citations
12.
Naumann, R. Wendel, David L. Tait, Robert V. Higgins, et al.. (2018). Patients with BRCA mutations have superior outcomes after intraperitoneal chemotherapy in optimally resected high grade ovarian cancer. Gynecologic Oncology. 151(3). 477–480. 21 indexed citations
13.
Naumann, R. Wendel & Jubilee Brown. (2018). Ovarian cancer screening with the Risk of Ovarian Cancer Algorithm (ROCA): Good, bad, or just expensive?. Gynecologic Oncology. 149(1). 117–120. 11 indexed citations
14.
Brown, Jubilee, Erin K. Crane, William E. Anderson, et al.. (2018). When Less Is More: Minimally Invasive Surgery Compared with Laparotomy for Interval Debulking After Neoadjuvant Chemotherapy in Women with Advanced Ovarian Cancer. Journal of Minimally Invasive Gynecology. 26(5). 902–909. 30 indexed citations
15.
Shah, Jaimin S., David M. Gershenson, Preetha Ramalingam, et al.. (2018). Accuracy of Intraoperative Frozen Section Diagnosis of Borderline Ovarian Tumors by Hospital Type. Journal of Minimally Invasive Gynecology. 26(1). 87–93. 20 indexed citations
16.
Tewari, Krishnansu S., Michael W. Sill, Bradley J. Monk, et al.. (2015). Prospective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study. Clinical Cancer Research. 21(24). 5480–5487. 53 indexed citations
17.
Ledermann, Jonathan A., Daniela Luvero, Aaron Shafer, et al.. (2014). Gynecologic Cancer InterGroup (GCIG) Consensus Review for Mucinous Ovarian Carcinoma. International Journal of Gynecological Cancer. 24(9 Suppl 3). S14–S19. 74 indexed citations
18.
Jhingran, Anuja, Lois M. Ramondetta, Diane C. Bodurka, et al.. (2013). A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I–IIIA (1988) uterine papillary serous carcinoma of the endometrium. Gynecologic Oncology. 129(2). 304–309. 20 indexed citations
19.
Zaid, Tarrik M., Jennifer K. Burzawa, Karen Basen‐Engquist, et al.. (2013). Use of social media to conduct a cross-sectional epidemiologic and quality of life survey of patients with neuroendocrine carcinoma of the cervix: A feasibility study. Gynecologic Oncology. 132(1). 149–153. 34 indexed citations
20.
Burzawa, Jennifer K., Kathleen M. Schmeler, Pamela T. Soliman, et al.. (2011). Prospective evaluation of insulin resistance among endometrial cancer patients. American Journal of Obstetrics and Gynecology. 204(4). 355.e1–355.e7. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cor D. de Kroon Breakdown of academic impact, for papers by Linda Duska Breakdown of academic impact, for papers by Lee-may Chen Breakdown of academic impact, for papers by Susan C. Modesitt Breakdown of academic impact, for papers by Ritu Salani Breakdown of academic impact, for papers by Shohreh Shahabi Breakdown of academic impact, for papers by Joseph L. Kelley Breakdown of academic impact, for papers by Jose Alejandro Rauh‐Hain Breakdown of academic impact, for papers by David E. Parkin Breakdown of academic impact, for papers by Christine H. Holschneider
Rankless by CCL
2026